| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.24 | 1e-07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.22 | 4e-06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.2 | 9e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.094 | 0.05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.083 | 0.07 |